Dr. Ernest Fraenkel's lab focuses on understanding how genetic risk factors for Alzheimer's disease affect cellular metabolism and communication. By using human-derived stem cells, the lab investigates the functions of risk alleles in different brain cell types, especially how they respond to stress and contribute to the mechanisms of Alzheimer's disease. The research aims to uncover potential pathways for future therapies.

Dr. Robert Guy Griffin's lab at MIT focuses on understanding the structures of amyloid proteins, which are crucial in diseases like Alzheimer's. The lab uses advanced techniques in nuclear magnetic resonance (NMR) to study how these proteins form and interact, particularly looking at how certain variations can affect their properties and the development of amyloid-related diseases. This research aims to provide atomic-level insights that could lead to new treatments for amyloid-related conditions.

Dr. Polina O. Anikeeva's lab at MIT specializes in using innovative technologies to explore how the brain communicates with the body's peripheral organs, particularly focusing on the gut. By combining nanomagnetic materials with viral tools, the lab aims to develop new ways to manipulate specific neurons remotely to gain insights into mood, motivation, and stress. This research could lead to new treatments for neurological and psychological disorders by understanding gut-brain interactions.

Dr. Mark Bathe's lab at MIT focuses on creating innovative vaccine platforms using synthetic DNA-based structures. Their research aims to improve how our immune system responds to serious viruses like HIV and influenza by optimizing the presentation of viral proteins. The lab seeks to understand how different properties of these DNA-based viral particles can harness immune responses to generate long-lasting immunity.

Professor Xuanhe Zhao's lab at MIT focuses on developing innovative biomedical devices to improve patient safety during heart surgery. One of their current projects involves creating an electrically conductive bioadhesive device that integrates with heart tissue without causing trauma or inflammation during placement or removal. This research aims to enhance the effectiveness of temporary cardiac pacing and reduce the risk of complications for patients undergoing cardiac surgery.

Professor Stephen L Buchwald's lab at MIT focuses on designing new chemical methods for creating complex organic molecules, which is vital for developing new drugs and therapies. The lab specializes in metal-catalyzed reactions, particularly using palladium and copper, to forge important chemical bonds that are often used in pharmaceuticals. Their work enhances the ability to synthesize important compounds more efficiently and safely, contributing significantly to advancements in medicine and human health.

Dr. Matthew G. Vander Heiden's lab focuses on understanding how cancer cells alter their metabolism to support rapid growth and proliferation. By studying the unique metabolic requirements of different cancer types, the lab aims to discover how these processes can be targeted for cancer therapy. The research combines advanced techniques in biochemistry and mouse models to explore the limitations and variations in nutrient usage by cancer cells, providing insights that could lead to new treatments.

The research lab led by Michal Caspi Tal at MIT focuses on understanding Lyme disease, specifically how to predict patient recovery and persistent symptoms following treatment. They are investigating immune biomarkers that can inform on the body's response to the bacteria Borrelia burgdorferi. Through innovative techniques, including a new technology called FLIP, the team aims to profile various immune responses and ultimately improve clinical outcomes for Lyme disease patients.

Dr. Kwanghun Chung's lab at MIT focuses on understanding Alzheimer's disease by studying the locus coeruleus, a brain region that is affected early in the disease. They analyze how this area connects with other parts of the brain and how those connections change with age and disease progression. By examining neuron populations and their properties, the lab aims to uncover the reasons behind the vulnerability of certain brain regions to Alzheimer's.

Professor Alan D. Grossman and his lab at MIT study how bacteria share and acquire genes through a process called horizontal gene transfer. They focus on understanding the roles of mobile genetic elements, like plasmids and conjugative elements, in bacterial evolution and survival, particularly using Bacillus subtilis as a model organism. The research aims to uncover the interactions between these elements and how they can affect the behavior and characteristics of bacterial populations.

Professor Anders Sejr Hansen's lab at MIT focuses on understanding how transcription factors (TFs) locate their specific binding sites on DNA within the crowded environment of the cell nucleus. They utilize advanced microscopy techniques that track single molecules in real-time, allowing them to observe TF behavior at an incredibly high resolution. This research has implications for synthetic biology and cancer, especially in understanding how mutations in TFs may contribute to disease.

Professor Daniel G. Anderson's research lab at MIT focuses on developing innovative mRNA vaccines for HIV. By combining cutting-edge computational design with biomedical engineering, the lab aims to create vaccines that can elicit a strong immune response, producing broadly neutralizing antibodies that can adapt to various strains of the virus. The lab's work is crucial for addressing the ongoing challenges in creating effective HIV vaccines, with the potential to significantly impact public health.

Dr. Daniel Leif Migdow Suess's lab focuses on studying iron-sulfur enzymes, which are important in many biological processes and diseases. The lab aims to uncover the mechanisms of these enzymes by developing synthetic models that resemble their natural forms and by improving the techniques used to analyze them. Through this work, the lab seeks to enhance our understanding of how these enzymes function, which could lead to better disease-targeted therapies.

Alan Jasanoff's lab at MIT focuses on developing advanced imaging techniques to better understand brain function at the molecular and cellular levels. By using novel genetically-encoded probes, they aim to visualize and analyze brain activity in living animals, helping to reveal the processes that influence behavior and learning. Their research holds the potential to transform neuroscience by providing insights into the connectivity and functionality of neural circuits while also improving diagnostic techniques for brain-related conditions.

Rebecca L Lamason's lab at MIT focuses on understanding how certain bacteria, specifically Spotted Fever Group Rickettsia, interact with their hosts to cause disease. The lab investigates the role of secreted bacterial proteins that manipulate host cell processes, aiming to unveil their complex life cycles and enhance our knowledge about tick-borne diseases. This research has the potential to lead to improved treatment and prevention strategies for these infections.

Dr. Tami D Lieberman's lab at MIT studies how the human microbiome evolves and adapts over time, focusing on the changes in bacterial populations that occur within individual people. They explore the factors that influence these changes and how it affects health, particularly in response to urban lifestyles. The ultimate goal is to enhance microbiome-targeted therapies by understanding these complex interactions.

Professor Laura Kiessling's lab at MIT focuses on developing new chemical tools to study the cell wall of Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. By visualizing and understanding the structure and changes of the bacterial cell envelope, the lab aims to identify new treatment strategies for drug-resistant strains of TB. Their research includes the creation of probes that can detect specific components of the mycobacterial cell wall and monitor how these components change during antibiotic treatment.

Dr. Mohammad Movassaghi's lab at MIT focuses on creating new strategies for synthesizing complex natural products, which are important for understanding their biological effects. The research aims to develop efficient methods for the total synthesis of these compounds, particularly those with significant biological activity. By exploring new chemical transformations, the lab seeks to unlock the potential of rare natural products for therapeutic use, paving the way for innovative treatments for human health issues.

Professor Ronald T. Raines' lab at MIT focuses on innovating protein chemistry to improve drug delivery methods. The research aims to develop new techniques for proteins to cross cellular membranes and target intracellular processes, which can lead to new therapies for serious diseases, including cancer. By modifying proteins chemically, the lab explores their potential therapeutic applications and how they can be harnessed effectively in biomedical research.

Dr. Peter T. So's lab focuses on advancing microscopy techniques to better understand cellular processes, particularly regarding aging and senescent cells. Using high-speed imaging and machine learning, the lab develops innovative technologies that allow scientists to identify and analyze cells without destroying them, providing insights into their functions and states. This research could transform how we study cellular responses in various tissues and improve our knowledge of age-related diseases.